

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.02576991 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.02576991 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81639523 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.58293240 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45404067 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44548070 |
| 7 | negative regulation of phagocytosis (GO:0050765) | 4.35442283 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.28323609 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.27998583 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.22030760 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.11524994 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.11524994 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.11524994 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.11524994 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.11524994 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.11524994 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 4.04840709 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99864063 |
| 19 | response to peptidoglycan (GO:0032494) | 3.80815646 |
| 20 | leukocyte aggregation (GO:0070486) | 3.80677905 |
| 21 | germinal center formation (GO:0002467) | 3.68677158 |
| 22 | positive thymic T cell selection (GO:0045059) | 3.67049233 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.62643270 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60655257 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.57802013 |
| 26 | detection of bacterium (GO:0016045) | 3.40078437 |
| 27 | regulation of B cell differentiation (GO:0045577) | 3.39079795 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.38862978 |
| 29 | detection of other organism (GO:0098543) | 3.38497433 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36507947 |
| 31 | regulation of mast cell degranulation (GO:0043304) | 3.35697953 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.32642352 |
| 33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.29529093 |
| 34 | respiratory burst (GO:0045730) | 3.28422136 |
| 35 | cellular extravasation (GO:0045123) | 3.27605236 |
| 36 | defense response to protozoan (GO:0042832) | 3.26580891 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.22766700 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16438260 |
| 39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13344024 |
| 40 | B cell homeostasis (GO:0001782) | 3.12940846 |
| 41 | response to interleukin-15 (GO:0070672) | 3.11564861 |
| 42 | negative thymic T cell selection (GO:0045060) | 3.10286658 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.08176557 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.08176557 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06515987 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.05678467 |
| 47 | response to type I interferon (GO:0034340) | 3.05498582 |
| 48 | thymic T cell selection (GO:0045061) | 3.04746576 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.01218426 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98920166 |
| 51 | response to protozoan (GO:0001562) | 2.98115616 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96462839 |
| 53 | myeloid dendritic cell activation (GO:0001773) | 2.96285387 |
| 54 | myeloid dendritic cell differentiation (GO:0043011) | 2.96239138 |
| 55 | response to host immune response (GO:0052572) | 2.95768530 |
| 56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.95768530 |
| 57 | cellular response to interleukin-15 (GO:0071350) | 2.95648440 |
| 58 | positive regulation of interferon-alpha production (GO:0032727) | 2.94872338 |
| 59 | regulation of leukocyte degranulation (GO:0043300) | 2.93527564 |
| 60 | negative T cell selection (GO:0043383) | 2.93221776 |
| 61 | granulocyte activation (GO:0036230) | 2.92319329 |
| 62 | tolerance induction (GO:0002507) | 2.92098306 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 2.91206008 |
| 64 | neutrophil activation (GO:0042119) | 2.90751701 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.90459682 |
| 66 | B cell mediated immunity (GO:0019724) | 2.90103889 |
| 67 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85641903 |
| 68 | positive T cell selection (GO:0043368) | 2.82929139 |
| 69 | T cell selection (GO:0045058) | 2.82693863 |
| 70 | Peyers patch development (GO:0048541) | 2.81961904 |
| 71 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.81961904 |
| 72 | response to host (GO:0075136) | 2.81895148 |
| 73 | response to host defenses (GO:0052200) | 2.81895148 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81895148 |
| 75 | positive regulation of isotype switching (GO:0045830) | 2.81879169 |
| 76 | natural killer cell differentiation (GO:0001779) | 2.77142209 |
| 77 | detection of external biotic stimulus (GO:0098581) | 2.76736654 |
| 78 | negative regulation of innate immune response (GO:0045824) | 2.76689684 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 2.72549619 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72213578 |
| 81 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70733646 |
| 82 | regulation of superoxide anion generation (GO:0032928) | 2.69295971 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 2.69220122 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.67717576 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.66819715 |
| 86 | regulation of B cell apoptotic process (GO:0002902) | 2.62732851 |
| 87 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.61185911 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.59941504 |
| 89 | lymphocyte homeostasis (GO:0002260) | 2.59409499 |
| 90 | positive regulation of B cell activation (GO:0050871) | 2.59157558 |
| 91 | T cell migration (GO:0072678) | 2.58971747 |
| 92 | modulation by virus of host process (GO:0019054) | 2.58942308 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.58552061 |
| 94 | leukocyte degranulation (GO:0043299) | 2.57892684 |
| 95 | mannose metabolic process (GO:0006013) | 2.57605487 |
| 96 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.57553849 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55700064 |
| 98 | modulation by symbiont of host cellular process (GO:0044068) | 2.55636969 |
| 99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54405139 |
| 100 | regulation of mast cell activation (GO:0033003) | 2.53943567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.63654447 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.02442415 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01503756 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.48423773 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43237766 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36793174 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34814754 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.28837908 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19841780 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.19005532 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.18483586 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14653827 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14437702 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07009886 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03315381 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.01608385 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.00901685 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98324648 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.97598864 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97079414 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.96385429 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88951821 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87486190 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85900354 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84246970 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83619251 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.83008638 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.82063491 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.81549725 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79987142 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.76523003 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74758364 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.74403432 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.71892530 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.71363977 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68842361 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68445683 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67822447 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64227617 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.61296642 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60704835 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59518302 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.57838228 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57329628 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55264880 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.53770112 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53274912 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51645028 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51559993 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48328344 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47079622 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40613306 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37786893 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37769431 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33400883 |
| 56 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33270918 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32837789 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30946333 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30096731 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29125680 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28059982 |
| 62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26019901 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26016761 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25106289 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24590192 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23736836 |
| 67 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22774644 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22373941 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22181378 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21603456 |
| 71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21594250 |
| 72 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20214261 |
| 73 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.20130429 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18658977 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18602755 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.18563057 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18394554 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18096140 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15390065 |
| 80 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15219061 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15058321 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14032452 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11551939 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10289247 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10063065 |
| 86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06617620 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06145403 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05884699 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03996130 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03965935 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03258750 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03007284 |
| 93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02429103 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01609081 |
| 95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01142813 |
| 96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01128153 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00578895 |
| 98 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00534020 |
| 99 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.99955482 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99604088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.09929103 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.76625060 |
| 3 | MP0003303_peritoneal_inflammation | 3.43186345 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.06932766 |
| 5 | MP0000685_abnormal_immune_system | 3.05389283 |
| 6 | MP0005387_immune_system_phenotype | 3.01624466 |
| 7 | MP0001790_abnormal_immune_system | 3.01624466 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.95708005 |
| 9 | MP0001800_abnormal_humoral_immune | 2.88343453 |
| 10 | MP0005671_abnormal_response_to | 2.72676795 |
| 11 | MP0002419_abnormal_innate_immunity | 2.52004043 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.50125262 |
| 13 | MP0002723_abnormal_immune_serum | 2.50104193 |
| 14 | MP0005025_abnormal_response_to | 2.48275469 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.47629195 |
| 16 | MP0001819_abnormal_immune_cell | 2.45215276 |
| 17 | MP0003724_increased_susceptibility_to | 2.42686045 |
| 18 | MP0009785_altered_susceptibility_to | 2.37411508 |
| 19 | MP0005451_abnormal_body_composition | 2.28469044 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.24243206 |
| 21 | MP0002398_abnormal_bone_marrow | 2.22949543 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.21314055 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.17244302 |
| 24 | MP0002405_respiratory_system_inflammati | 2.13070779 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.08258664 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.01610616 |
| 27 | MP0000716_abnormal_immune_system | 1.98246489 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.92267568 |
| 29 | MP0008260_abnormal_autophagy | 1.91703584 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.89719633 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.89493567 |
| 32 | MP0002722_abnormal_immune_system | 1.87327448 |
| 33 | MP0009278_abnormal_bone_marrow | 1.82802646 |
| 34 | MP0004947_skin_inflammation | 1.81676821 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.77136531 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.76504017 |
| 37 | MP0002429_abnormal_blood_cell | 1.74236712 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.72461130 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.63038076 |
| 40 | MP0006082_CNS_inflammation | 1.61641821 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.59936360 |
| 42 | MP0001873_stomach_inflammation | 1.59931510 |
| 43 | MP0001853_heart_inflammation | 1.55468389 |
| 44 | MP0000858_altered_metastatic_potential | 1.42083697 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.40909363 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.36467125 |
| 47 | MP0002132_abnormal_respiratory_system | 1.31590595 |
| 48 | MP0008469_abnormal_protein_level | 1.31195637 |
| 49 | MP0000490_abnormal_crypts_of | 1.29609385 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.23539926 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.23539926 |
| 52 | MP0005310_abnormal_salivary_gland | 1.22439260 |
| 53 | MP0004510_myositis | 1.17991314 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.17940603 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.17066009 |
| 56 | MP0003866_abnormal_defecation | 1.14130499 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.13312416 |
| 58 | MP0009840_abnormal_foam_cell | 1.09401652 |
| 59 | MP0002933_joint_inflammation | 1.05220332 |
| 60 | MP0003828_pulmonary_edema | 1.02990683 |
| 61 | MP0003075_altered_response_to | 1.02888891 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.02621930 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.00398968 |
| 64 | MP0002019_abnormal_tumor_incidence | 1.00218616 |
| 65 | MP0009764_decreased_sensitivity_to | 0.99323188 |
| 66 | MP0003183_abnormal_peptide_metabolism | 0.93697677 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.91377693 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 0.88666950 |
| 69 | MP0002006_tumorigenesis | 0.87813070 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.87672710 |
| 71 | MP0005390_skeleton_phenotype | 0.86663299 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.84787406 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.83749573 |
| 74 | MP0001851_eye_inflammation | 0.82442776 |
| 75 | MP0004381_abnormal_hair_follicle | 0.82404983 |
| 76 | MP0000343_altered_response_to | 0.82369851 |
| 77 | MP0003448_altered_tumor_morphology | 0.80557143 |
| 78 | MP0000313_abnormal_cell_death | 0.78774917 |
| 79 | MP0009763_increased_sensitivity_to | 0.73952315 |
| 80 | MP0010307_abnormal_tumor_latency | 0.72659512 |
| 81 | MP0003795_abnormal_bone_structure | 0.72370876 |
| 82 | MP0000609_abnormal_liver_physiology | 0.71620131 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.71469337 |
| 84 | MP0001663_abnormal_digestive_system | 0.69949808 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.69727901 |
| 86 | MP0005166_decreased_susceptibility_to | 0.68488584 |
| 87 | MP0003091_abnormal_cell_migration | 0.68096946 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.65975648 |
| 89 | MP0008004_abnormal_stomach_pH | 0.65890949 |
| 90 | MP0009931_abnormal_skin_appearance | 0.64921868 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.64850955 |
| 92 | MP0005621_abnormal_cell_physiology | 0.63218565 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.62835381 |
| 94 | MP0005501_abnormal_skin_physiology | 0.62513626 |
| 95 | MP0003077_abnormal_cell_cycle | 0.59481097 |
| 96 | MP0000249_abnormal_blood_vessel | 0.59053238 |
| 97 | MP0003111_abnormal_nucleus_morphology | 0.59022750 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58551835 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.58202871 |
| 100 | MP0002009_preneoplasia | 0.57827232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.89521821 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.41840332 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.25966017 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.12805818 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.12690160 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.05330118 |
| 7 | Meningitis (HP:0001287) | 4.03043523 |
| 8 | Cellulitis (HP:0100658) | 3.86284221 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 3.81366321 |
| 10 | Obstructive lung disease (HP:0006536) | 3.81366321 |
| 11 | Colitis (HP:0002583) | 3.80336302 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 3.78921407 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 3.78007998 |
| 14 | Recurrent viral infections (HP:0004429) | 3.77038625 |
| 15 | Inflammation of the large intestine (HP:0002037) | 3.72334037 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.72332784 |
| 17 | Myositis (HP:0100614) | 3.56379861 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.55572234 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54878241 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44227722 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44227722 |
| 22 | Stomatitis (HP:0010280) | 3.39405296 |
| 23 | Gastrointestinal stroma tumor (HP:0100723) | 3.32396444 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23467198 |
| 25 | Orchitis (HP:0100796) | 3.20429661 |
| 26 | Vasculitis (HP:0002633) | 3.18803182 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.17980225 |
| 28 | Increased IgE level (HP:0003212) | 3.17692766 |
| 29 | Recurrent skin infections (HP:0001581) | 3.12471900 |
| 30 | Encephalitis (HP:0002383) | 3.11172419 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 2.95196722 |
| 32 | Lymphopenia (HP:0001888) | 2.83663651 |
| 33 | Optic neuritis (HP:0100653) | 2.83473974 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.83473974 |
| 35 | Abnormality of T cells (HP:0002843) | 2.71924351 |
| 36 | Gingivitis (HP:0000230) | 2.71609387 |
| 37 | Viral hepatitis (HP:0006562) | 2.71438495 |
| 38 | Verrucae (HP:0200043) | 2.70596479 |
| 39 | Papilloma (HP:0012740) | 2.70596479 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.69611674 |
| 41 | Osteomyelitis (HP:0002754) | 2.68204495 |
| 42 | Urticaria (HP:0001025) | 2.66880990 |
| 43 | Increased IgM level (HP:0003496) | 2.59032670 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.57646294 |
| 45 | Petechiae (HP:0000967) | 2.56885454 |
| 46 | Recurrent sinusitis (HP:0011108) | 2.51218833 |
| 47 | Chest pain (HP:0100749) | 2.51141270 |
| 48 | Fatigue (HP:0012378) | 2.49213319 |
| 49 | Recurrent lower respiratory tract infections (HP:0002783) | 2.46971348 |
| 50 | Pustule (HP:0200039) | 2.45303444 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.43638583 |
| 52 | Emphysema (HP:0002097) | 2.42416072 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.41743102 |
| 54 | Hypertensive crisis (HP:0100735) | 2.36542542 |
| 55 | Sepsis (HP:0100806) | 2.30707551 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.29928388 |
| 57 | Restrictive lung disease (HP:0002091) | 2.26268791 |
| 58 | IgM deficiency (HP:0002850) | 2.23877521 |
| 59 | Epistaxis (HP:0000421) | 2.21711759 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.19736161 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.18934377 |
| 62 | Granulocytopenia (HP:0001913) | 2.15618648 |
| 63 | Increased serum ferritin (HP:0003281) | 2.13484285 |
| 64 | Purpura (HP:0000979) | 2.12987136 |
| 65 | T lymphocytopenia (HP:0005403) | 2.12907575 |
| 66 | Episodic fever (HP:0001954) | 2.12039816 |
| 67 | Premature loss of primary teeth (HP:0006323) | 2.10451577 |
| 68 | IgG deficiency (HP:0004315) | 2.07948428 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.06219013 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.05246618 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04904623 |
| 72 | Recurrent pneumonia (HP:0006532) | 2.04558769 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.02762668 |
| 74 | Skin rash (HP:0000988) | 2.00595919 |
| 75 | Lymphoma (HP:0002665) | 2.00448242 |
| 76 | Arterial thrombosis (HP:0004420) | 2.00264608 |
| 77 | Hypochromic anemia (HP:0001931) | 1.99804994 |
| 78 | Dysostosis multiplex (HP:0000943) | 1.99646834 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 1.97988844 |
| 80 | Hemoptysis (HP:0002105) | 1.97086129 |
| 81 | Loss of speech (HP:0002371) | 1.96317429 |
| 82 | Abnormality of T cell number (HP:0011839) | 1.95187118 |
| 83 | Skin ulcer (HP:0200042) | 1.94358859 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93091522 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93091522 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93091522 |
| 87 | Glomerulopathy (HP:0100820) | 1.91953527 |
| 88 | Vertebral compression fractures (HP:0002953) | 1.91386034 |
| 89 | Anorexia (HP:0002039) | 1.86212430 |
| 90 | IgA deficiency (HP:0002720) | 1.85936871 |
| 91 | Progressive external ophthalmoplegia (HP:0000590) | 1.82262381 |
| 92 | Abnormality of the prostate (HP:0008775) | 1.78620188 |
| 93 | Gingival bleeding (HP:0000225) | 1.78269666 |
| 94 | Arthralgia (HP:0002829) | 1.77932374 |
| 95 | Increased connective tissue (HP:0009025) | 1.76883618 |
| 96 | Microvesicular hepatic steatosis (HP:0001414) | 1.76257313 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75318467 |
| 98 | Abnormality of the pleura (HP:0002103) | 1.74552713 |
| 99 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74173859 |
| 100 | Leukocytosis (HP:0001974) | 1.73662236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.18360345 |
| 2 | ERN1 | 3.95805115 |
| 3 | SMG1 | 3.09473918 |
| 4 | IRAK4 | 2.92309498 |
| 5 | PRPF4B | 2.91523728 |
| 6 | RIPK4 | 2.87430680 |
| 7 | MAP2K3 | 2.50522755 |
| 8 | TRIB3 | 2.44974077 |
| 9 | TYK2 | 2.07457248 |
| 10 | TESK2 | 2.05876232 |
| 11 | BLK | 2.05029890 |
| 12 | MAP3K11 | 1.91010874 |
| 13 | TBK1 | 1.90899661 |
| 14 | GRK6 | 1.88004888 |
| 15 | IRAK3 | 1.80838172 |
| 16 | TNK2 | 1.80552721 |
| 17 | MAP3K14 | 1.75965562 |
| 18 | TAOK2 | 1.66347087 |
| 19 | SIK1 | 1.66329581 |
| 20 | CSF1R | 1.65315013 |
| 21 | BTK | 1.59634979 |
| 22 | EPHB1 | 1.58709827 |
| 23 | NME2 | 1.57652150 |
| 24 | TAOK1 | 1.50126257 |
| 25 | CSK | 1.47889443 |
| 26 | SIK3 | 1.42660454 |
| 27 | ZAP70 | 1.41243047 |
| 28 | TXK | 1.34864350 |
| 29 | JAK3 | 1.34573209 |
| 30 | EEF2K | 1.33658597 |
| 31 | IKBKB | 1.28090404 |
| 32 | IKBKE | 1.27267908 |
| 33 | SYK | 1.27116711 |
| 34 | MAP3K3 | 1.26858582 |
| 35 | VRK2 | 1.26692157 |
| 36 | MAP3K10 | 1.25997080 |
| 37 | CDK12 | 1.24210791 |
| 38 | FES | 1.21815891 |
| 39 | HCK | 1.14073358 |
| 40 | SIK2 | 1.03805815 |
| 41 | KDR | 1.02719134 |
| 42 | ICK | 1.02319189 |
| 43 | LYN | 0.99968562 |
| 44 | PRKD2 | 0.97901640 |
| 45 | CDC42BPA | 0.97770049 |
| 46 | ARAF | 0.97450912 |
| 47 | MAP3K1 | 0.96774272 |
| 48 | ITK | 0.91108545 |
| 49 | MAPK11 | 0.90060154 |
| 50 | FGR | 0.88702925 |
| 51 | JAK1 | 0.86832576 |
| 52 | PTK6 | 0.84850906 |
| 53 | TESK1 | 0.82543047 |
| 54 | LRRK2 | 0.82329770 |
| 55 | CDK4 | 0.81364446 |
| 56 | MAP3K13 | 0.81234140 |
| 57 | IRAK2 | 0.81137640 |
| 58 | STK10 | 0.80526976 |
| 59 | LCK | 0.78602376 |
| 60 | FGFR4 | 0.77237672 |
| 61 | KIT | 0.74521240 |
| 62 | CLK1 | 0.72927248 |
| 63 | PIM2 | 0.70142266 |
| 64 | MARK3 | 0.68781689 |
| 65 | MAP2K2 | 0.68590902 |
| 66 | TEC | 0.67650762 |
| 67 | MARK2 | 0.67060574 |
| 68 | IRAK1 | 0.65746826 |
| 69 | TAOK3 | 0.65694941 |
| 70 | MAPK12 | 0.62457367 |
| 71 | HIPK2 | 0.62193918 |
| 72 | MAP3K8 | 0.60892110 |
| 73 | MAPKAPK2 | 0.58166667 |
| 74 | PKN2 | 0.57329443 |
| 75 | PDPK1 | 0.56176815 |
| 76 | PDK1 | 0.54415053 |
| 77 | CDK8 | 0.52237979 |
| 78 | MAPK7 | 0.51342241 |
| 79 | PAK4 | 0.50331091 |
| 80 | BRAF | 0.50063775 |
| 81 | RPS6KC1 | 0.49612679 |
| 82 | RPS6KL1 | 0.49612679 |
| 83 | CHUK | 0.49398190 |
| 84 | CDC7 | 0.47362365 |
| 85 | MST4 | 0.46556736 |
| 86 | KSR2 | 0.45590556 |
| 87 | JAK2 | 0.45426444 |
| 88 | MAPK4 | 0.44584459 |
| 89 | MATK | 0.40896643 |
| 90 | CDK9 | 0.39455655 |
| 91 | MAPKAPK3 | 0.37174895 |
| 92 | CDK7 | 0.36705601 |
| 93 | PRKCQ | 0.35465798 |
| 94 | RPS6KA1 | 0.34613912 |
| 95 | RPS6KA6 | 0.32913500 |
| 96 | MAP2K6 | 0.31004524 |
| 97 | PASK | 0.30581724 |
| 98 | FYN | 0.29999762 |
| 99 | TTN | 0.29862170 |
| 100 | PIM1 | 0.29262870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.13823082 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.86980386 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54929618 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49056631 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.45552181 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.31136208 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.26028611 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.07971810 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04137660 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99661528 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.97943740 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.97093775 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89648346 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83355621 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.83173022 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.83099565 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81538136 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77854711 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72388247 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70076873 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.64957524 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64026041 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63752263 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58816287 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53014454 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.52961550 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51482727 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48995909 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.41192689 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.39480885 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.38455053 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.38071577 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36771728 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36301901 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33601395 |
| 36 | DNA replication_Homo sapiens_hsa03030 | 1.29343401 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27927832 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27297312 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.26879908 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.25322346 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24572430 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18825193 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.18070798 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17488693 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.12641494 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10695777 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.10208426 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07963941 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01945827 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.00357836 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98792736 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95873580 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.94940995 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.94319406 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93164636 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90728868 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89582439 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89127329 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88325916 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.87338147 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81823614 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 0.80900090 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 0.80418395 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75688239 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72297574 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69981970 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.69237967 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65644386 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.64281238 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64037386 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63414304 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61191832 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60811778 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60076644 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.58642706 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58320611 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58026654 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57336385 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57104325 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56613773 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56508465 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55961796 |
| 83 | Spliceosome_Homo sapiens_hsa03040 | 0.55168420 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52702506 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52080038 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52013093 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.48338781 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47414668 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46477227 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46411005 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44799093 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43999044 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42773548 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38126553 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37315480 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36396124 |
| 97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35768842 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.35368798 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35095649 |
| 100 | Mismatch repair_Homo sapiens_hsa03430 | 0.34103743 |

